CorVel Corp
CRVL
ISIN null / Valor 921843
CorVel Corp
UMushroom community rating:
About company
CorVel Corporation is a publicly traded provider of technology-driven workers’ compensation and disability management services, combining claims administration, medical bill review and payment, provider network access, telemedicine and utilization-review services with analytics and case management tools to help insurers, third-party administrators, self-insured employers and government entities manage workplace injury and absence costs. Headquartered in Irvine, California, the company operates a nationwide network of medical providers and pharmacy services and markets a proprietary claims and healthcare management platform that automates workflows, controls medical spend and supports return-to-work programs, generating revenue from service fees, technology subscriptions and managed-care arrangements.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (02.04.2026):
CorVel Corp reported results for the third quarter of fiscal year 2026 (quarter ended December 31, 2025). Q3 revenues rose to $235.6 million and diluted EPS was $0.47, both modest gains versus the prior-year quarter. Year-to-date (nine months) results were stronger: revenues of $709.98 million (up 7%) and diluted EPS of $1.53 (up 16%). The company exited the quarter with about $230.0 million in cash, no borrowings, and continued share repurchases while highlighting material progress on AI and technology integration.
Revenue and EPS
Quarter: revenues $235.6M (up ~3% YoY) and diluted EPS $0.47 (up ~2% YoY). Nine months: revenues $709.98M (up 7% YoY) and diluted EPS $1.53 (up 16% YoY).
Profitability and margins
Q3 gross profit was $54.9M (23% gross margin) vs. $52.9M a year ago. Income from operations for the quarter was $32.2M and net income was $24.2M.
Liquidity and balance sheet
CorVel Corp ended the quarter with $230.0M in cash and cash equivalents and no borrowings. Total assets were $644.8M (compared to $546.0M at March 31, 2025); customer deposits rose to $115.4M and accounts receivable were about $102.1M.
Capital return and share count
The company repurchased $13.4M of common stock in the quarter. Diluted weighted shares were ~51.58M in Q3 2026 versus ~52.04M in Q3 2025, supporting the modest EPS lift.
Strategic initiatives
Management emphasized material advances in AI across products, services, and development processes, plus accelerated integration of a recent strategic acquisition and a robust 2026 software roadmap intended to improve efficiency and outcomes for P&C and CERIS customers.
Forward-looking note
The release includes a standard safe-harbor for forward-looking statements; the company cautions that projected productivity gains from automation and AI are subject to risks and may not be realized as expected.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
2939 M
Market cap (USD)
160,881
Daily traded volume (Shares)
113.15 / 111.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
